IP Library › Patent Application 13759454
Patent Application
App. No. 13/759,454

Trace Elements

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/759,454
Abstract

The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronisation preparation. The synchronisation preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable theurapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvents. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocydic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocydic lactones include doramectin, ivermectin, abamectin and moxidectin.

Claims (14)

1 . An injectable trace element solution, which includes

(a) the metals selenium, zinc, and manganese, with at least one of the metals metal(s) provided in the form of an EDTA complex;

(b) at least one component selected from the group consisting of a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a hormonal synchronisation preparation.

2 . The solution as claimed in claim 1 , further comprising at least one compound selected from the group consisting of iodine, copper, chromium and iron.

3 . The solution as claimed in claim 1 , wherein the antibiotic(s) are used at least one function selected from the group consisting of to treat infectious diseases and to limit the incidence of infectious diseases.

4 . The solution as claimed in claim 1 , wherein the vaccine includes at least one compound selected from the group consisting of antigens and a combination of antigens and adjuvents.

5 . The solution as claimed in claim 1 , wherein the growth stimulants include at least one compound selected from the group consisting of zeranol, estradiol, testosterone, progesterone and trenbolone acetate.

6 . The solution as claimed in claim 1 , wherein the dewormer includes at least one compound selected from the group consisting of macrocydic lactones, leramizoles, benzimidazoles and salicylanilides.

7 . The solution as claimed in claim 6 , wherein the macrocydic lactones include at least one compound selected from the group consisting of doramectin, ivermectin, abamectin and moxidectin.

8 . The solution as claimed in claim 1 , wherein the solution includes a concentration of the metal(s) of at least 20 mg/ml.

9 . The solution as claimed in claim 1 , wherein the EDTA complex is obtained by means of at least one compound selected from the group consisting of sodium EDTA, sodium hydroxide EDTA acid and potassium EDTA.

10 . The solution as claimed in claim 1 , further comprising chloro-cresol as preservative.

11 . The solution as claimed in claim 1 , wherein the solution is prepared in a continuous batch process.

12 . The solution of claim 1 , wherein a total metal concentration from the metals is at least 60 mg/ml.